Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 29, 2022 | Post-IPO Equity | $50M | 1 | — | — | Detail |
Nov 8, 2021 | Post-IPO Debt | $400M | — | — | — | Detail |
Apr 9, 2021 | Post-IPO Equity | $300M | — | — | — | Detail |
Jun 7, 2020 | Post-IPO Equity | $200M | — | — | — | Detail |
Apr 30, 2019 | Post-IPO Equity | $34M | 3 | Foris Ventures | — | Detail |
Aug 24, 2018 | Post-IPO Equity | $46M | — | — | — | Detail |
Jan 17, 2018 | Grant | $25M | 1 | National Institutes of Health | — | Detail |
Aug 3, 2017 | Post-IPO Equity | $50M | 2 | DSM , Vivo Capital | — | Detail |
Oct 6, 2016 | Post-IPO Equity | $5M | — | — | — | Detail |
Oct 6, 2016 | Post-IPO Debt | $25M | — | — | — | Detail |
Oct 14, 2015 | Post-IPO Equity | $57.60M | — | — | — | Detail |
Jul 29, 2015 | Post-IPO Equity | $140.97M | 3 | Temasek Holdings , Total | — | Detail |
Jul 31, 2014 | Post-IPO Debt | $10.85M | — | — | — | Detail |
May 23, 2014 | Post-IPO Equity | $75M | — | — | — | Detail |
Apr 22, 2014 | Post-IPO Equity | $4M | — | — | — | Detail |
Jun 11, 2013 | Post-IPO Debt | $30M | — | — | — | Detail |
Feb 27, 2012 | Post-IPO Equity | $83.70M | 5 | — | — | Detail |
Oct 28, 2011 | Post-IPO Equity | $7M | — | — | — | Detail |
Sep 28, 2010 | Post-IPO Equity | $13.77M | 1 | — | — | Detail |
Sep 28, 2010 | IPO | $84.80M | — | — | — | Detail |
Jun 26, 2010 | Series D | $133M | 4 | Temasek Holdings | — | Detail |
Dec 1, 2009 | Grant | $24.30M | — | — | — | Detail |
Oct 1, 2009 | Series C | $41.75M | 4 | — | — | Detail |
Aug 14, 2008 | Series B | $21M | 4 | — | — | Detail |
Feb 7, 2008 | Series Unknown | $2.35M | — | — | — | Detail |
Sep 19, 2007 | Series B | $70M | 4 | DAG Ventures | — | Detail |
Oct 12, 2006 | Series A | $20M | 3 | Khosla Ventures | — | Detail |